Related Experiment Video
Updated: Oct 10, 2025
Intraoperative Assessment of Resection Margins in Oral Cavity Cancer: This is the Way
Published on: May 10, 2021
Melanoma trials that defined surgical management: Overview of trials that established NCCN margin guidelines
Jeremy Sharib1, Craig L Slingluff2, Georgia M Beasley1
1Department of Surgery, Duke University, Durham, North Carolina, USA.
Abstract:
Since the observation that clearance of all visible and microscopic tumors from cutaneous melanoma is critical to prevent a recurrence, wide surgical margins have been central to surgical dogma. In the last several decades, more conservative margin widths have been vigorously studied by surgical investigators to lessen wound complications, the need for reconstruction, and healthcare costs. This review summarizes surgeon-led clinical trials that define current guidelines and highlights the challenges to initiate and perform trials today.
Insights
Wide surgical margins for cutaneous melanoma are standard, but research explores conservative options to reduce complications and costs. This review examines trials defining current guidelines and challenges in conducting new research.
Area of Science:
- Dermatology
- Surgical Oncology
- Clinical Trials
Background:
- Wide surgical margins have historically been the standard of care for cutaneous melanoma to prevent recurrence.
- Recent decades have seen increased investigation into more conservative margin widths.
Observation:
- Complete tumor clearance, both visible and microscopic, is essential for preventing melanoma recurrence.
- Conservative margins aim to minimize wound complications, reconstructive needs, and healthcare expenses.
Findings:
- This review synthesizes findings from surgeon-led clinical trials on melanoma surgical margins.
- Current guidelines for surgical margins in cutaneous melanoma are presented.
- Challenges associated with initiating and conducting contemporary clinical trials are highlighted.
Implications:
- The findings inform evidence-based surgical practices for cutaneous melanoma management.
- Understanding trial challenges may facilitate future research into optimal surgical margins.
- This review supports a shift towards potentially less invasive melanoma treatments.
